Drugs / Enterococcus faecium
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT04074421 Comparator | May 2020 → Jun 2022 | irritable bowel syndrome | Second Affiliated Hospital, School of Medicine, Zhejiang University | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Enterococcus faecium | “A probiotic called Enterococcus faecium, 500mg, triple one day for 4 weeks.” NCT04074421 ↗ |